Development of microvascular complications in type 1 diabetic patients 10 years follow-up
- PMID: 16879113
- PMCID: PMC7192638
- DOI: 10.17305/bjbms.2006.3171
Development of microvascular complications in type 1 diabetic patients 10 years follow-up
Abstract
Microvascular diabetic complications are the most common causes of morbidity and mortality of patients with type 1 disease. Diabetic nephropathy is becoming the single most common cause of end stage renal failure, while diabetic retinopathy is the most common cause of blindness in working-age population. The main aim of the study was to evaluate the progression of late microvascular complications in type 1 diabetic patients treated by conventional or intensified insulin regimen over the period of 10 years. We selected a random sample of 32 patients, including 14 males and 18 females, aged 30,6 +/- 11,8 years, with average duration of the disease of 4,8 +/- 3,2 years. They did not show signs of overt diabetic nephropathy, while 5 patients had background retinopathy. All the patients had their fasting and postprandial glycaemia, HbAlc, 24/hour proteinuria, blood pressure, height and weight measured and body mass index calculated (BMI). There was a trend towards increasing values of HbAlc (6.9 +/- 0.8 vs. 7.4 +/- 1.0 %, p < 0.05), fasting glycaemia (6.8 +/- 08 vs. 7.8 +/- 1.2 mmol/l, p < 0.05), postprandial glycaemia (9.2 +/- 1.5 vs. 11.3 +/- 1.9 mmol/l, p <0.01), systolic and diastolic blood pressure values (120.0 +/- 10.8 vs. 128.5 +/- 16.8 mmHg, p<0.05; and 73.4 +/- 8.1 vs. 79.8 +/- 9.8 mmHg, p< 0.05) although no hypertensive patient was diagnosed. There were 11 persons (34.4%) with persistent proteinuria of 200 mg/24 hour or more and significant difference in overall proteinuria in 10 yrs period (121.3 +/- 37.3 vs. 312.8 +/- 109.9 mg/24 h, p< 0.001). Overall, 9 persons (28.1%) were diagnosed with simple, background retinopathy, but 6 of them (18.8%) had signs of proliferative form of the disease. The results indicate significant changes in progression of proteinuria in both groups although retinopathic progression was observed but was not significant in the intensively treated group.
Similar articles
-
The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.Diabetes Res Clin Pract. 1997 Mar;35(2-3):113-21. doi: 10.1016/s0168-8227(97)01386-7. Diabetes Res Clin Pract. 1997. PMID: 9179466
-
[Dynamics of diabetic nephropathy and other complications of type I diabetes mellitus in the period of 1996-2002 (data from 2 Kaunas outpatient polyclinics)].Medicina (Kaunas). 2003;39 Suppl 1:51-8. Medicina (Kaunas). 2003. PMID: 12761421 Lithuanian.
-
Predictors of mortality and end-stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy.Diabet Med. 2000 Oct;17(10):727-34. doi: 10.1046/j.1464-5491.2000.00372.x. Diabet Med. 2000. PMID: 11110506
-
Review of the relationship between renal and retinal microangiopathy in diabetes mellitus patients.Curr Diabetes Rev. 2010 Mar;6(2):88-101. doi: 10.2174/157339910790909387. Curr Diabetes Rev. 2010. PMID: 20034365 Review.
-
Associations between diabetic retinopathy and systemic risk factors.Hong Kong Med J. 2016 Dec;22(6):589-99. doi: 10.12809/hkmj164869. Epub 2016 Oct 24. Hong Kong Med J. 2016. PMID: 27779095 Review.
Cited by
-
Vascular endothelial growth factor (VEGF)-related single nucleotide polymorphisms rs10738760 and rs6921438 are not associated with diabetic retinopathy (DR) in Slovenian patients with type 2 diabetes mellitus (T2DM).Bosn J Basic Med Sci. 2017 Nov 20;17(4):328-332. doi: 10.17305/bjbms.2017.2068. Bosn J Basic Med Sci. 2017. PMID: 29055125 Free PMC article.
-
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2. Cochrane Database Syst Rev. 2023. PMID: 36815723 Free PMC article. Review.
References
-
- Campbell IW, Lebovitz H. Diabetes mellitus. Oxford: Health press; 1996. p. 25.
-
- Raine AEG. Evolution worldwide of the treatment of patients with advanced diabetic nephropathy by renal replacement therapy. In: Mogensen CE, editor. The Kidney and hypertension in Diabetes mellitus. Boston Kluwer Academic Publishers; 1994. pp. 449–458.
-
- The 1993 USRDS Annual Data Report. Incidence and causes of treated ESRD. Am. J. Kid. Dis. 1993;22(Suppl.2):38–45.
-
- Colucciello M. Diabetic retinopathy. Postgraduate medicine. 2004;116(1):57–64. - PubMed
-
- Molich ME. Management of early diabetic nephropathy. Am. J. Med. 1997;102(4):392–398. - PubMed